Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.
French Reference Center on Paraneoplastic Neurological Syndrome, Hospices civils de Lyon, Lyon, France.
Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.
Paraneoplastic cerebellar degenerations with anti-Yo antibodies (Yo-PCD) are rare syndromes caused by an auto-immune response against neuronal antigens (Ags) expressed by tumor cells. However, the mechanisms responsible for such immune tolerance breakdown are unknown. We characterized 26 ovarian carcinomas associated with Yo-PCD for their tumor immune contexture and genetic status of the 2 onconeural Yo-Ags, CDR2 and CDR2L. Yo-PCD tumors differed from the 116 control tumors by more abundant T and B cells infiltration occasionally organized in tertiary lymphoid structures harboring CDR2L protein deposits. Immune cells are mainly in the vicinity of apoptotic tumor cells, revealing tumor immune attack. Moreover, contrary to un-selected ovarian carcinomas, 65% of our Yo-PCD tumors presented at least one somatic mutation in Yo-Ags, with a predominance of missense mutations. Recurrent gains of the CDR2L gene with tumor protein overexpression were also present in 59% of Yo-PCD patients. Overall, each Yo-PCD ovarian carcinomas carried at least one genetic alteration of Yo-Ags. These data demonstrate an association between massive infiltration of Yo-PCD tumors by activated immune effector cells and recurrent gains and/or mutations in autoantigen-encoding genes, suggesting that genetic alterations in tumor cells trigger immune tolerance breakdown and initiation of the auto-immune disease.
抗 Yo 抗体相关副肿瘤性小脑变性 (Yo-PCD) 是由肿瘤细胞表达的神经元抗原 (Ags) 引起的自身免疫反应引起的罕见综合征。然而,导致这种免疫耐受破坏的机制尚不清楚。我们对 26 例与 Yo-PCD 相关的卵巢癌进行了研究,分析了它们的肿瘤免疫微环境以及 2 个神经肿瘤 Yo-Ags(CDR2 和 CDR2L)的遗传状态。与 116 例对照肿瘤相比,Yo-PCD 肿瘤的 T 细胞和 B 细胞浸润更为丰富,偶尔会形成含有 CDR2L 蛋白沉积的三级淋巴结构。免疫细胞主要存在于凋亡的肿瘤细胞附近,表明存在肿瘤免疫攻击。此外,与非选择性卵巢癌不同,我们研究的 Yo-PCD 肿瘤中有 65%至少存在 1 个 Yo-Ags 的体细胞突变,且主要为错义突变。在 59%的 Yo-PCD 患者中还存在 CDR2L 基因的反复获得和/或肿瘤蛋白过表达。总体而言,每个 Yo-PCD 卵巢癌都至少存在一个 Yo-Ags 的遗传改变。这些数据表明,Yo-PCD 肿瘤中激活的免疫效应细胞的大量浸润与自身抗原编码基因的反复获得和/或突变之间存在关联,提示肿瘤细胞的遗传改变触发了免疫耐受破坏和自身免疫疾病的发生。